{"entity":{"type":"insider","cik":"0001692929","url":"/insider/0001692929","json_url":"/insider/0001692929.json","name":"SCHAFFER DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":7,"first":"2018-01-31","last":"2021-10-22","span_basis":"filed_date"},"name_variants":[{"name":"SCHAFFER DAVID","source":"filing","n_filings":7,"first_seen":"2018-01-31","last_seen":"2021-10-22"}],"transactions":[{"id":5497215,"accession":"0001567619-21-018628","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-018628","line_url":"/filing/0001567619-21-018628#line-3","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":30.9962,"price_display":"31.00","price_state":"stated","total_value":58892.78,"total_display":"58,892.78","total_whole":"58,893","shares_owned_after":901215.0,"shares_owned_after_display":"901,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-22","scope":"insider"},{"id":5497212,"accession":"0001567619-21-018628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-018628","line_url":"/filing/0001567619-21-018628#line-2","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22820.0,"shares_display":"22,820","price_per_share":31.5581,"price_display":"31.56","price_state":"stated","total_value":720155.842,"total_display":"720,155.84","total_whole":"720,156","shares_owned_after":903115.0,"shares_owned_after_display":"903,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-22","scope":"insider"},{"id":5497209,"accession":"0001567619-21-018628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-018628","line_url":"/filing/0001567619-21-018628#line-1","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11565.0,"shares_display":"11,565","price_per_share":31.0221,"price_display":"31.02","price_state":"stated","total_value":358770.5865,"total_display":"358,770.59","total_whole":"358,771","shares_owned_after":925935.0,"shares_owned_after_display":"925,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-20","filed_date":"2021-10-22","scope":"insider"},{"id":5525012,"accession":"0001567619-21-017751","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-21-017751","line_url":"/filing/0001567619-21-017751","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12385.0,"shares_display":"12,385","price_per_share":26.907523084376262,"price_display":"26.91","price_state":"stated","total_value":333249.6734,"total_display":"333,249.67","total_whole":"333,250","shares_owned_after":942049.0,"shares_owned_after_display":"942,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-30","filed_date":"2021-10-01","scope":"insider","n_lines":2},{"id":5525007,"accession":"0001567619-21-017751","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-017751","line_url":"/filing/0001567619-21-017751","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16871.0,"shares_display":"16,871","price_per_share":28.606104516626164,"price_display":"28.61","price_state":"stated","total_value":482613.5893,"total_display":"482,613.59","total_whole":"482,614","shares_owned_after":950585.0,"shares_owned_after_display":"950,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-10-01","scope":"insider","n_lines":3},{"id":4277110,"accession":"0001567619-21-017624","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-21-017624","line_url":"/filing/0001567619-21-017624","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13912.0,"shares_display":"13,912","price_per_share":30.527064174813113,"price_display":"30.53","price_state":"stated","total_value":424692.5168,"total_display":"424,692.52","total_whole":"424,693","shares_owned_after":966856.0,"shares_owned_after_display":"966,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-28","filed_date":"2021-09-29","scope":"insider","n_lines":2},{"id":4277103,"accession":"0001567619-21-017624","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-017624","line_url":"/filing/0001567619-21-017624","is_derivative":false,"issuer_cik":"0001650648","issuer_name":"4D Molecular Therapeutics Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001650648","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19332.0,"shares_display":"19,332","price_per_share":32.88980126215601,"price_display":"32.89","price_state":"stated","total_value":635825.638,"total_display":"635,825.64","total_whole":"635,826","shares_owned_after":986925.0,"shares_owned_after_display":"986,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-29","scope":"insider","n_lines":3},{"id":2288707,"accession":"0000904454-20-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-20-000112","line_url":"/filing/0000904454-20-000112#line-1","is_derivative":false,"issuer_cik":"0001590560","issuer_name":"uniQure N.V.","issuer_ticker":"QURE","issuer_name_source":null,"issuer_url":"/issuer/0001590560","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":806.0,"shares_display":"806","price_per_share":62.27,"price_display":"62.27","price_state":"stated","total_value":50189.62,"total_display":"50,189.62","total_whole":"50,190","shares_owned_after":44915.0,"shares_owned_after_display":"44,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-28","filed_date":"2020-01-30","scope":"insider"},{"id":8308843,"accession":"0000904454-19-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000130","line_url":"/filing/0000904454-19-000130#line-1","is_derivative":false,"issuer_cik":"0001590560","issuer_name":"uniQure N.V.","issuer_ticker":"QURE","issuer_name_source":null,"issuer_url":"/issuer/0001590560","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1210.0,"shares_display":"1,210","price_per_share":31.31,"price_display":"31.31","price_state":"stated","total_value":37885.1,"total_display":"37,885.10","total_whole":"37,885","shares_owned_after":45721.0,"shares_owned_after_display":"45,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-30","scope":"insider"},{"id":8308838,"accession":"0000904454-19-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000109","line_url":"/filing/0000904454-19-000109#line-1","is_derivative":false,"issuer_cik":"0001590560","issuer_name":"uniQure N.V.","issuer_ticker":"QURE","issuer_name_source":null,"issuer_url":"/issuer/0001590560","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":30.71,"price_display":"30.71","price_state":"stated","total_value":230325.0,"total_display":"230,325.00","total_whole":"230,325","shares_owned_after":43701.0,"shares_owned_after_display":"43,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-17","filed_date":"2019-01-29","scope":"insider"},{"id":6492022,"accession":"0000904454-18-000087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000087","line_url":"/filing/0000904454-18-000087#line-1","is_derivative":false,"issuer_cik":"0001590560","issuer_name":"uniQure N.V.","issuer_ticker":"QURE","issuer_name_source":null,"issuer_url":"/issuer/0001590560","owner_cik":"0001692929","owner_name":"SCHAFFER DAVID","owner_display_name":"SCHAFFER DAVID","owner_url":"/insider/0001692929","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2878.0,"shares_display":"2,878","price_per_share":18.53,"price_display":"18.53","price_state":"stated","total_value":53329.34,"total_display":"53,329.34","total_whole":"53,329","shares_owned_after":15314.0,"shares_owned_after_display":"15,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-29","filed_date":"2018-01-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001650648","name":"4D Molecular Therapeutics Inc.","url":"/issuer/0001650648","role":"Director","n_filings":3,"first_seen":"2021-09-29","last_seen":"2021-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001590560","name":"uniQure N.V.","url":"/issuer/0001590560","role":"Director","n_filings":4,"first_seen":"2018-01-31","last_seen":"2020-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001692929","retrieved_at":"2026-08-23T03:00:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}